{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:51:07Z","timestamp":1790661067275,"version":"4.1.0"},"reference-count":125,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T00:00:00Z","timestamp":1702425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:p>The over-prescription of opioid analgesics is a growing problem in the field of addiction, which has reached epidemic-like proportions in North America. Over the past decade, oxycodone has gained attention as the leading opioid responsible for the North America opioid crisis. Oxycodone is the most incriminated drug in the early years of the epidemic of opioid use disorder in USA (roughly 1999\u20132016). The number of preclinical articles on oxycodone is rapidly increasing. Several publications have already compared oxycodone with other opioids, focusing mainly on their analgesic properties. The aim of this review is to focus on the genomic and epigenetic regulatory features of oxycodone compared with other opioid agonists. Our aim is to initiate a discussion of perceptible differences in the pharmacological response observed with these various opioids, particularly after repeated administration in preclinical models commonly used to study drug dependence potential.<\/jats:p>","DOI":"10.3389\/fpsyt.2023.1229439","type":"journal-article","created":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T04:33:19Z","timestamp":1702441999000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":23,"title":["Oxycodone, an opioid like the others?"],"prefix":"10.3389","volume":"14","author":[{"given":"Nicolas","family":"Marie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Noble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,12,13]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"567","DOI":"10.5055\/jom.2022.0751","article-title":"Equianalgesic potency ratios of opioids used in patient-controlled analgesia: a network meta-analysis","volume":"18","author":"Dinges","year":"2022","journal-title":"J Opioid Manag"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/j.1742-7843.2011.00814.x","article-title":"Pharmacokinetic-pharmacodynamic modelling of opioids in healthy human volunteers. A minireview","volume":"110","author":"Ing Lorenzini","year":"2012","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1111\/j.1399-6576.1991.tb03364.x","article-title":"Intravenous morphine and oxycodone for pain after abdominal surgery","volume":"35","author":"Kalso","year":"1991","journal-title":"Acta Anaesthesiol Scand"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jpainsymman.2005.01.010","article-title":"Oxycodone","volume":"29","author":"Kalso","year":"2005","journal-title":"J Pain Symptom Manag"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"PHARMREV-AR-2021-000506","DOI":"10.1124\/pharmrev.121.000506","article-title":"Oxycodone: a current perspective on its pharmacology, abuse and Pharmacotherapeutic developments","author":"Barrett","year":"2023","journal-title":"Pharmacol Rev"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1663\/0013-0001(2003)057[0295:AEFTTO]2.0.CO;2","article-title":"Archaeological evidence for the tradition of psychoactive plant use in the Old World","volume":"57","author":"Merlin","year":"2003","journal-title":"Econ Bot"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/s1522-8649(03)50051-8","article-title":"Scophedal (SEE) was it a fad or a miracle drug?","volume":"21","author":"Defalque","year":"2003","journal-title":"Bull Anesth Hist"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1136\/bmjspcare-2017-001457","article-title":"Efficacy, tolerability and acceptability of oxycodone for cancer-related pain in adults: an updated Cochrane systematic review","volume":"8","author":"Schmidt-Hansen","year":"2018","journal-title":"BMJ Support Palliat Care"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"CD003870","DOI":"10.1002\/14651858.CD003870.pub7","article-title":"Oxycodone for cancer-related pain","volume":"2022","author":"Schmidt-Hansen","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1007\/s10571-020-01013-y","article-title":"Oxycodone in the opioid epidemic: high \u201cliking\u201d, \u201cwanting\u201d, and abuse liability","volume":"41","author":"Kibaly","year":"2021","journal-title":"Cell Mol Neurobiol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.addbeh.2017.05.030","article-title":"Increased use of heroin as an initiating opioid of abuse","volume":"74","author":"Cicero","year":"2017","journal-title":"Addict Behav"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13011-020-00308-z","article-title":"Recent changes in trends of opioid overdose deaths in North America","volume":"15","author":"Imtiaz","year":"2020","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1093\/epirev\/mxaa011","article-title":"The evolving overdose epidemic: synthetic opioids and rising stimulant-related harms","volume":"42","author":"Jones","year":"2020","journal-title":"Epidemiol Rev"},{"key":"ref14","first-page":"330","article-title":"Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors","volume":"45","author":"Raynor","year":"1994","journal-title":"Mol Pharmacol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"3139","DOI":"10.1007\/s00213-014-3490-9","article-title":"Impact of P-glycoprotein at the blood-brain barrier on the uptake of heroin and its main metabolites: behavioral effects and consequences on the transcriptional responses and reinforcing properties","volume":"231","author":"Seleman","year":"2014","journal-title":"Psychopharmacology"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1124\/jpet.105.094276","article-title":"Comparison of the antinociceptive response to morphine and morphine-like compounds in male and female Sprague-Dawley rats","volume":"316","author":"Peckham","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"5653","DOI":"10.1038\/s41598-020-62530-w","article-title":"N-Phenethyl substitution in 14-Methoxy-N-methylmorphinan-6-ones turns selective \u03bc opioid receptor ligands into dual \u03bc\/\u03b4 opioid receptor agonists","volume":"10","author":"Dumitrascuta","year":"2020","journal-title":"Sci Rep"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.clpt.2006.01.009","article-title":"Pharmacokinetics and pharmacodynamics of oral oxycodone in healthy human subjects: role of circulating active metabolites","volume":"79","author":"Lalovic","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"395","DOI":"10.2174\/1570159043359477","article-title":"Buprenorphine: a unique drug with complex pharmacology","volume":"2","author":"Lutfy","year":"2004","journal-title":"Curr Neuropharmacol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1080\/10611860601141606","article-title":"P-glycoprotein mediates brain-to-blood efflux transport of buprenorphine across the blood-brain barrier","volume":"15","author":"Suzuki","year":"2007","journal-title":"J Drug Target"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.2174\/1570159X15666170504095823","article-title":"Opioids and the blood-brain barrier: a dynamic interaction with consequences on drug disposition in brain","volume":"15","author":"Chaves","year":"2017","journal-title":"Curr Neuropharmacol"},{"key":"ref22","first-page":"688","article-title":"Comparison of pharmacological activities of buprenorphine and norbuprenorphine: norbuprenorphine is a potent opioid agonist","volume":"297","author":"Huang","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.phrs.2017.01.018","article-title":"P-gp\/ABCB1 exerts differential impacts on brain and fetal exposure to norbuprenorphine","volume":"119","author":"Liao","year":"2017","journal-title":"Pharmacol Res"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1097\/ALN.0b013e318238fea0","article-title":"Buprenorphine metabolites, buprenorphine-3-glucuronide and norbuprenorphine-3-glucuronide, are biologically active","volume":"115","author":"Brown","year":"2011","journal-title":"Anesthesiology"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1016\/0024-3205(91)90150-a","article-title":"Mu receptor binding of some commonly used opioids and their metabolites","volume":"48","author":"Chen","year":"1991","journal-title":"Life Sci"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1016\/S1877-8860(09)70005-9","article-title":"Pharmacology of oxycodone: does it explain why oxycodone has become a bestselling strong opioid?","volume":"1","author":"Lemberg","year":"2009","journal-title":"Scandinavian Journal of Pain"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.yrtph.2010.12.007","article-title":"Uniform assessment and ranking of opioid \u03bc receptor binding constants for selected opioid drugs","volume":"59","author":"Volpe","year":"2011","journal-title":"Regul Toxicol Pharmacol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1124\/jpet.104.082560","article-title":"Pharmacokinetic-pharmacodynamic modeling of the antinociceptive effect of buprenorphine and fentanyl in rats: role of receptor equilibration kinetics","volume":"313","author":"Yassen","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.taap.2005.08.002","article-title":"Buprenorphine is protective against the depressive effects of norbuprenorphine on ventilation","volume":"212","author":"M\u00e9garbane","year":"2006","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1097\/ADM.0b013e31806c9202","article-title":"Buprenorphine: the basic pharmacology revisited","volume":"1","author":"Cowan","year":"2007","journal-title":"J Addict Med"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1093\/bja\/ael051","article-title":"Buprenorphine induces ceiling in respiratory depression but not in analgesia","volume":"96","author":"Dahan","year":"2006","journal-title":"Br J Anaesth"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1111\/bph.12305","article-title":"Levels of heroin and its metabolites in blood and brain extracellular fluid after i.v. heroin administration to freely moving rats","volume":"170","author":"Gott\u00e5s","year":"2013","journal-title":"Br J Pharmacol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jflm.2018.12.005","article-title":"Metabolism and metabolomics of opiates: a long way of forensic implications to unravel","volume":"61","author":"Dinis-Oliveira","year":"2019","journal-title":"J Forensic Legal Med"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/S0006-2952(01)00689-X","article-title":"Mu opioid receptor-mediated G-protein activation by heroin metabolites: evidence for greater efficacy of 6-monoacetylmorphine compared with morphine","volume":"62","author":"Selley","year":"2001","journal-title":"Biochem Pharmacol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/0024-3205(94)90069-8","article-title":"Morphine and morphine metabolite kinetics in the rat brain as assessed by transcortical microdialysis","volume":"55","author":"Barjavel","year":"1994","journal-title":"Life Sci"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1124\/dmd.108.022087","article-title":"Involvement of the pyrilamine transporter, a putative organic cation transporter, in blood-brain barrier transport of oxycodone","volume":"36","author":"Okura","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1097\/00000539-199502000-00016","article-title":"Pharmacokinetics and pharmacodynamics of oxycodone when given intravenously and rectally to adult patients with cancer pain","volume":"80","author":"Leow","year":"1995","journal-title":"Anesth Analg"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1093\/bja\/aet337","article-title":"Central nervous system penetration of oxycodone after intravenous and epidural administration","volume":"112","author":"Kokki","year":"2014","journal-title":"Br J Anaesth"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1600-0773.1992.tb00441.x","article-title":"Antinociceptive effects and central nervous system depression caused by oxycodone and morphine in rats","volume":"70","author":"P\u00f6yhi\u00e4","year":"1992","journal-title":"Pharmacol Toxicol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/0024-3205(87)90459-0","article-title":"Oxymorphone-naltrexonazine, a mixed opiate agonist-antagonist","volume":"41","author":"Galetta","year":"1987","journal-title":"Life Sci"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1213\/ane.0b013e3181605a15","article-title":"Pharmacological characterization of noroxymorphone as a new opioid for spinal analgesia","volume":"106","author":"Lemberg","year":"2008","journal-title":"Anesth Analg"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1096\/fj.03-0612fje","article-title":"Morphine exposure and abstinence define specific stages of gene expression in the rat nucleus accumbens","volume":"18","author":"Spijker","year":"2004","journal-title":"FASEB J"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/s0169-328x(03)00057-3","article-title":"Microarray analysis of genes expressed in the frontal cortex of rats chronically treated with morphine and after naloxone precipitated withdrawal","volume":"112","author":"Ammon","year":"2003","journal-title":"Brain Res Mol Brain Res"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"108598","DOI":"10.1016\/j.drugalcdep.2021.108598","article-title":"Repeated morphine exposure activates synaptogenesis and other neuroplasticity-related gene networks in the dorsomedial prefrontal cortex of male and female rats","volume":"221","author":"Liu","year":"2021","journal-title":"Drug Alcohol Depend"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1124\/dmd.109.029199","article-title":"Regulation of gene expression in brain tissues of rats repeatedly treated by the highly abused opioid agonist, oxycodone: microarray profiling and gene mapping analysis","volume":"38","author":"Hassan","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"e101807","DOI":"10.1371\/journal.pone.0101807","article-title":"Effects of an oxycodone conjugate vaccine on oxycodone self-administration and oxycodone-induced brain gene expression in rats","volume":"9","author":"Pravetoni","year":"2014","journal-title":"PLoS One"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.neuroscience.2018.07.032","article-title":"Chronic oxycodone self-administration altered reward-related genes in the ventral and dorsal striatum of C57BL\/6J mice: an RNA-seq analysis","volume":"393","author":"Zhang","year":"2018","journal-title":"Neuroscience"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.brainresbull.2022.09.023","article-title":"An RNA-seq study of the mPFC of rats with different addiction phenotypes","volume":"191","author":"McFalls","year":"2022","journal-title":"Brain Res Bull"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.brainres.2010.02.070","article-title":"The kappa-opioid receptor is upregulated in the spinal cord and locus ceruleus but downregulated in the dorsal root ganglia of morphine tolerant rats","volume":"1326","author":"Li","year":"2010","journal-title":"Brain Res"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.3892\/ijmm.2012.1132","article-title":"Regulation of mammalian MOR-1 gene expression after chronic treatment with morphine","volume":"30","author":"Prenus","year":"2012","journal-title":"Int J Mol Med"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/0-306-47611-8_10","article-title":"Morphine upregulates kappa-opioid receptors of human lymphocytes","volume":"493","author":"Suzuki","year":"2001","journal-title":"Adv Exp Med Biol"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1007\/s10571-020-01015-w","article-title":"Regulation of opioid receptors by their endogenous opioid peptides","volume":"41","author":"Gupta","year":"2021","journal-title":"Cell Mol Neurobiol"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.pain.2008.10.011","article-title":"The pro-nociceptive effects of remifentanil or surgical injury in mice are associated with a decrease in delta-opioid receptor mRNA levels: prevention of the nociceptive response by on-site delivery of enkephalins","volume":"141","author":"Caba\u00f1ero","year":"2009","journal-title":"Pain"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.imlet.2005.05.009","article-title":"Morphine-induced changes in the activity of proopiomelanocortin and prodynorphin systems in zymosan-induced peritonitis in mice","volume":"101","author":"Chadzinska","year":"2005","journal-title":"Immunol Lett"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"7","DOI":"10.2119\/molmed.2012.00318","article-title":"In vivo regulation of the \u03bc opioid receptor: role of the endogenous opioid agents","volume":"19","author":"Gonzalez-Nunez","year":"2013","journal-title":"Mol Med"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1073\/pnas.0710902105","article-title":"Opioid neuropeptide genotypes in relation to heroin abuse: dopamine tone contributes to reversed mesolimbic proenkephalin expression","volume":"105","author":"Nikoshkov","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.neuroscience.2019.04.047","article-title":"Sex differences in neuroplasticity- and stress-related gene expression and protein levels in the rat Hippocampus following oxycodone conditioned place preference","volume":"410","author":"Randesi","year":"2019","journal-title":"Neuroscience"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1111\/pme.12918","article-title":"Differential effects of oxycodone, hydrocodone, and morphine on activation levels of signaling molecules","volume":"17","author":"Emery","year":"2016","journal-title":"Pain Med"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-022-01837-8","article-title":"Single cell transcriptomics reveals distinct transcriptional responses to oxycodone and buprenorphine by iPSC-derived brain organoids from patients with opioid use disorder","author":"Ho","year":"2022","journal-title":"Mol Psychiatry"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"107778","DOI":"10.1016\/j.neuropharm.2019.107778","article-title":"Reversal of oxycodone conditioned place preference by oxytocin: promoting global DNA methylation in the hippocampus","volume":"160","author":"Fan","year":"2019","journal-title":"Neuropharmacology"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"3789","DOI":"10.12659\/MSM.910550","article-title":"Effect of Sirtuin-1 on synaptic plasticity in nucleus Accumbens in a rat model of heroin addiction","volume":"24","author":"Xia","year":"2018","journal-title":"Med Sci Monit"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1002\/jnr.24427","article-title":"Naloxone reversed cognitive impairments induced by repeated morphine under heavy perceptual load in the 5-choice serial reaction time task","volume":"97","author":"Guo","year":"2019","journal-title":"J Neurosci Res"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"135984","DOI":"10.1016\/j.neulet.2021.135984","article-title":"Levo-tetrahydropalmatine attenuates the acquisition of fentanyl-induced conditioned place preference and the changes in ERK and CREB phosphorylation expression in mice","volume":"756","author":"Du","year":"2021","journal-title":"Neurosci Lett"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.neulet.2016.07.047","article-title":"Blockade of cannabinoid CB1 receptor attenuates the acquisition of morphine-induced conditioned place preference along with a downregulation of ERK, CREB phosphorylation, and BDNF expression in the nucleus accumbens and hippocampus","volume":"630","author":"Zhang","year":"2016","journal-title":"Neurosci Lett"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"20183","DOI":"10.1038\/srep20183","article-title":"RACK1 promotes maintenance of morphine-associated memory via activation of an ERK-CREB dependent pathway in hippocampus","volume":"6","author":"Liu","year":"2016","journal-title":"Sci Rep"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s10571-013-0011-z","article-title":"Changes in the levels of p-ERK, p-CREB, and c-fos in rat mesocorticolimbic dopaminergic system after morphine-induced conditioned place preference: the role of acute and subchronic stress","volume":"34","author":"Haghparast","year":"2014","journal-title":"Cell Mol Neurobiol"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1080\/00952990.2022.2069574","article-title":"Quetiapine attenuates the acquisition of morphine-induced conditioned place preference and reduces ERK phosphorylation in the hippocampus and cerebral cortex","volume":"48","author":"Khezri","year":"2022","journal-title":"Am J Drug Alcohol Abuse"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.ejphar.2008.11.031","article-title":"Levo-tetrahydropalmatine attenuates oxycodone-induced conditioned place preference in rats","volume":"602","author":"Liu","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"4459","DOI":"10.1073\/pnas.0501076102","article-title":"Genome-wide analysis of cAMP-response element binding protein occupancy, phosphorylation, and target gene activation in human tissues","volume":"102","author":"Zhang","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/epi.12036","article-title":"Molecular pathways controlling inhibitory receptor expression","volume":"53","author":"Grabenstatter","year":"2012","journal-title":"Epilepsia"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1046\/j.1471-4159.2003.02156.x","article-title":"Upregulation of NMDAR1 subunit gene expression in cortical neurons via a PKA-dependent pathway","volume":"88","author":"Lau","year":"2004","journal-title":"J Neurochem"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/mp.2013.104","article-title":"Evidence from mouse and man for a role of neuregulin 3 in nicotine dependence","volume":"19","author":"Turner","year":"2014","journal-title":"Mol Psychiatry"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"32416","DOI":"10.1074\/jbc.M111.258970","article-title":"cAMP-response element (CRE)-mediated transcription by activating transcription factor-4 (ATF4) is essential for circadian expression of the Period2 gene","volume":"286","author":"Koyanagi","year":"2011","journal-title":"J Biol Chem"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/B978-0-12-407703-4.00001-3","article-title":"Diverse roles for MAPK signaling in circadian clocks","volume":"84","author":"Goldsmith","year":"2013","journal-title":"Adv Genet"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"3638","DOI":"10.1111\/bph.13152","article-title":"Acute morphine affects the rat circadian clock via rhythms of phosphorylated ERK1\/2 and GSK3\u03b2 kinases and Per1 expression in the rat suprachiasmatic nucleus","volume":"172","author":"Pa\u010desov\u00e1","year":"2015","journal-title":"Br J Pharmacol"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.biopsych.2019.06.027","article-title":"Epigenetic mechanisms of opioid addiction","volume":"87","author":"Browne","year":"2020","journal-title":"Biol Psychiatry"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"11804","DOI":"10.3390\/ijms231911804","article-title":"Epigenetic modulation of opioid receptors by drugs of abuse","volume":"23","author":"Reid","year":"2022","journal-title":"Int J Mol Sci"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s12031-014-0317-4","article-title":"Inhibition of histone deacetylase in the basolateral amygdala facilitates morphine context-associated memory formation in rats","volume":"55","author":"Wang","year":"2015","journal-title":"J Mol Neurosci"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.brainres.2016.10.007","article-title":"Effects of histone deacetylase inhibitor sodium butyrate on heroin seeking behavior in the nucleus accumbens in rats","volume":"1652","author":"Chen","year":"2016","journal-title":"Brain Res"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.biopsych.2016.09.015","article-title":"Striatal H3K27 acetylation linked to glutamatergic gene dysregulation in human heroin abusers holds promise as therapeutic target","volume":"81","author":"Egervari","year":"2017","journal-title":"Biol Psychiatry"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"113644","DOI":"10.1016\/j.bbr.2021.113644","article-title":"JQ1 attenuates psychostimulant- but not opioid-induced conditioned place preference","volume":"418","author":"Babigian","year":"2022","journal-title":"Behav Brain Res"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1038\/s41598-021-82206-3","article-title":"Oxycodone self-administration activates the mitogen-activated protein kinase\/mitogen- and stress-activated protein kinase (MAPK-MSK) signaling pathway in the rat dorsal striatum","volume":"11","author":"Blackwood","year":"2021","journal-title":"Sci Rep"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"e13025","DOI":"10.1111\/adb.13025","article-title":"Oxytocin prevents cue-induced reinstatement of oxycodone seeking: involvement of DNA methylation in the hippocampus","volume":"26","author":"Fan","year":"2021","journal-title":"Addict Biol"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"612200","DOI":"10.3389\/fphar.2020.612200","article-title":"Role of GABRD gene methylation in the nucleus Accumbens in heroin-seeking behavior in rats","volume":"11","author":"Hong","year":"2020","journal-title":"Front Pharmacol"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"e12730","DOI":"10.1111\/adb.12730","article-title":"DNMT3a in the hippocampal CA1 is crucial in the acquisition of morphine self-administration in rats","volume":"25","author":"Zhang","year":"2020","journal-title":"Addict Biol"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.3390\/ijms18091991","article-title":"Identification of circulating miRNAs differentially regulated by opioid treatment","volume":"18","author":"Toyama","year":"2017","journal-title":"Int J Mol Sci"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"109918","DOI":"10.1016\/j.biopha.2020.109918","article-title":"Altered serum microRNA expression profile in subjects with heroin and methamphetamine use disorder","volume":"125","author":"Gu","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"8641","DOI":"10.1523\/JNEUROSCI.0630-16.2016","article-title":"The brain-enriched MicroRNA miR-9-3p regulates synaptic plasticity and memory","volume":"36","author":"Sim","year":"2016","journal-title":"J Neurosci"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"pyv025","DOI":"10.1093\/ijnp\/pyv025","article-title":"Dopamine receptor D2 and associated microRNAs are involved in stress susceptibility and resistance to escitalopram treatment","volume":"18","author":"Zhang","year":"2015","journal-title":"Int J Neuropsychopharmacol"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3389\/fnmol.2016.00020","article-title":"MicroRNAs are involved in the development of morphine-induced analgesic tolerance and regulate functionally relevant changes in Serpini1","volume":"9","author":"Tapocik","year":"2016","journal-title":"Front Mol Neurosci"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1261\/rna.2775511","article-title":"microRNA-Seq reveals cocaine-regulated expression of striatal microRNAs","volume":"17","author":"Eipper-Mains","year":"2011","journal-title":"RNA"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1093\/ijnp\/pyz015","article-title":"Overexpression of miR-9 in the nucleus Accumbens increases oxycodone self-administration","volume":"22","author":"Mavrikaki","year":"2019","journal-title":"Int J Neuropsychopharmacol"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.neubiorev.2018.06.006","article-title":"Role of pharmacokinetic and pharmacodynamic parameters in neuroadaptations induced by drugs of abuse, with a focus on opioids and psychostimulants","volume":"106","author":"Marie","year":"2018","journal-title":"Neurosci Biobehav Rev"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s00213-011-2223-6","article-title":"Chronic and intermittent morphine treatment differently regulates opioid and dopamine systems: a role in locomotor sensitization","volume":"216","author":"Le Marec","year":"2011","journal-title":"Psychopharmacology"},{"key":"ref95","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.pnpbp.2012.10.013","article-title":"Different patterns of administration modulate propensity of methadone and buprenorphine to promote locomotor sensitization in mice","volume":"40","author":"Allouche","year":"2013","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"ref96","first-page":"12","article-title":"Pharmacokinetics of buprenorphine after intravenous administration in the mouse","volume":"45","author":"Yu","year":"2006","journal-title":"J Am Assoc Lab Anim Sci"},{"key":"ref97","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1111\/j.1745-7254.2005.00101.x","article-title":"Effects of l-tetrahydropalmatine on locomotor sensitization to oxycodone in mice","volume":"26","author":"Liu","year":"2005","journal-title":"Acta Pharmacol Sin"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"e12727","DOI":"10.1111\/adb.12727","article-title":"The role of 6-acetylmorphine in heroin-induced reward and locomotor sensitization in mice","volume":"25","author":"Kvello","year":"2020","journal-title":"Addict Biol"},{"key":"ref99","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.pbb.2013.06.010","article-title":"Oxycodone-induced conditioned place preference and sensitization of locomotor activity in adolescent and adult mice","volume":"110","author":"Niikura","year":"2013","journal-title":"Pharmacol Biochem Behav"},{"key":"ref100","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1007\/s00213-013-3298-z","article-title":"Effects of repeated exposure to morphine in adolescent and adult male C57BL\/6J mice: age-dependent differences in locomotor stimulation, sensitization, and body weight loss","volume":"231","author":"Koek","year":"2014","journal-title":"Psychopharmacology"},{"key":"ref101","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s00213-012-2847-1","article-title":"Attenuated effects of experimenter-administered heroin in adolescent vs. adult male rats: physical withdrawal and locomotor sensitization","volume":"225","author":"Doherty","year":"2013","journal-title":"Psychopharmacology"},{"key":"ref102","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/7854_2012_202","article-title":"Modeling relapse in animals","volume":"13","author":"Martin-Fardon","year":"2013","journal-title":"Curr Top Behav Neurosci"},{"key":"ref103","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.coph.2004.11.001","article-title":"Neurobiology of craving, conditioned reward and relapse","volume":"5","author":"Weiss","year":"2005","journal-title":"Curr Opin Pharmacol"},{"key":"ref104","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1159\/000327680","article-title":"Critical evaluation of the use of extinction paradigms for the assessment of opioid-induced conditioned place preference in rats","volume":"87","author":"Rutten","year":"2011","journal-title":"Pharmacology"},{"key":"ref105","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/j.1369-1600.2006.00009.x","article-title":"Effects of venlafaxine and desipramine on heroin-induced conditioned place preference in the rat","volume":"11","author":"Tzschentke","year":"2006","journal-title":"Addict Biol"},{"key":"ref106","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ejphar.2010.07.036","article-title":"Effects of the NOP receptor agonist Ro65-6570 on the acquisition of opiate- and psychostimulant-induced conditioned place preference in rats","volume":"645","author":"Rutten","year":"2010","journal-title":"Eur J Pharmacol"},{"key":"ref107","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0306-4522(96)00322-3","article-title":"Intracerebroventricular orphanin FQ\/nociceptin suppresses dopamine release in the nucleus accumbens of anaesthetized rats","volume":"75","author":"Murphy","year":"1996","journal-title":"Neuroscience"},{"key":"ref108","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1046\/j.1471-4159.1999.0730179.x","article-title":"Orphanin FQ\/nociceptin modulation of mesolimbic dopamine transmission determined by microdialysis","volume":"73","author":"Murphy","year":"1999","journal-title":"J Neurochem"},{"key":"ref109","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/s0196-9781(00)00250-3","article-title":"Nociceptin differentially affects morphine-induced dopamine release from the nucleus accumbens and nucleus caudate in rats","volume":"21","author":"Di Giannuario","year":"2000","journal-title":"Peptides"},{"key":"ref110","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s002130000609","article-title":"Orphanin FQ\/nociceptin attenuates motor stimulation and changes in nucleus accumbens extracellular dopamine induced by cocaine in rats","volume":"154","author":"Lutfy","year":"2001","journal-title":"Psychopharmacology"},{"key":"ref111","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/sj.bjp.0704806","article-title":"Actions of orphanin FQ\/nociceptin on rat ventral tegmental area neurons in vitro","volume":"136","author":"Zheng","year":"2002","journal-title":"Br J Pharmacol"},{"key":"ref112","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.ejphar.2012.11.050","article-title":"Retrodialysis of N\/OFQ into the nucleus accumbens shell blocks cocaine-induced increases in extracellular dopamine and locomotor activity","volume":"699","author":"Vazquez-DeRose","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"ref113","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.1111\/ejn.12709","article-title":"Rapid dopamine transmission within the nucleus accumbens: dramatic difference between morphine and oxycodone delivery","volume":"40","author":"Vander Weele","year":"2014","journal-title":"Eur J Neurosci"},{"key":"ref114","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.neuropharm.2019.03.019","article-title":"Male and female mice develop escalation of heroin intake and dependence following extended access","volume":"151","author":"Towers","year":"2019","journal-title":"Neuropharmacology"},{"key":"ref115","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s00213-006-0353-z","article-title":"Escalation of methamphetamine self-administration in rats: a dose-effect function","volume":"186","author":"Kitamura","year":"2006","journal-title":"Psychopharmacology"},{"key":"ref116","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1126\/science.282.5387.298","article-title":"Transition from moderate to excessive drug intake: change in hedonic set point","volume":"282","author":"Ahmed","year":"1998","journal-title":"Science"},{"key":"ref117","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1111\/j.1369-1600.2011.00385.x","article-title":"Drug specificity in extended access cocaine and heroin self-administration","volume":"17","author":"Lenoir","year":"2012","journal-title":"Addict Biol"},{"key":"ref118","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/npp.2014.188","article-title":"Compulsive-like responding for opioid analgesics in rats with extended access","volume":"40","author":"Wade","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"ref119","doi-asserted-by":"publisher","first-page":"3603","DOI":"10.1007\/s12035-018-1318-z","article-title":"Molecular Adaptations in the Rat Dorsal Striatum and Hippocampus Following Abstinence-Induced Incubation of Drug Seeking After Escalated Oxycodone Self-Administration","volume":"56","author":"Blackwood","year":"2019","journal-title":"Mol Neurobiol"},{"key":"ref120","doi-asserted-by":"publisher","first-page":"1035350","DOI":"10.3389\/fnbeh.2022.1035350","article-title":"Ranking the contribution of behavioral measures comprising oxycodone self-administration to reinstatement of drug-seeking in male and female rats","volume":"16","author":"Guha","year":"2022","journal-title":"Front Behav Neurosci"},{"key":"ref121","doi-asserted-by":"crossref","DOI":"10.1016\/j.nsa.2023.102819","article-title":"Comparison of the abuse liability of heroin, morphine and oxycodone in a model of intravenous self-administration in rats","author":"Geoffroy","year":"2023","journal-title":"Neuroscience Applied"},{"key":"ref122","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.neuroscience.2019.07.030","article-title":"Escalated Oxycodone Self-Administration Causes Differential Striatal mRNA Expression of FGFs and IEGs Following Abstinence-Associated Incubation of Oxycodone Craving","volume":"415","author":"Blackwood","year":"2019","journal-title":"Neuroscience"},{"key":"ref123","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1038\/sj.npp.1301479","article-title":"Abuse liability of prescription opioids compared to heroin in morphine-maintained heroin abusers","volume":"33","author":"Comer","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"ref124","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s11916-019-0751-7","article-title":"Oxycodone\u2019s Unparalleled Addictive Potential: Is it Time for a Moratorium?","volume":"23","author":"Remillard","year":"2019","journal-title":"Curr Pain Headache Rep"},{"key":"ref125","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.neuropharm.2019.02.008","article-title":"Respiratory depression and brain hypoxia induced by opioid drugs: Morphine, oxycodone, heroin, and fentanyl","volume":"151","author":"Kiyatkin","year":"2019","journal-title":"Neuropharmacology"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2023.1229439\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,28]],"date-time":"2023-12-28T00:07:38Z","timestamp":1703722058000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2023.1229439\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,13]]},"references-count":125,"alternative-id":["10.3389\/fpsyt.2023.1229439"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2023.1229439","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,13]]},"article-number":"1229439"}}